BDF Gestion’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.44M Sell
3,710
-471
-11% -$188K 0.2% 119
2026
Q2
$3.32M Sell
4,181
-471
-10% -$175K 0.44% 55
2026
Q1
$1.36M Buy
+4,652
New +$1.53M 0.18% 128
2025
Q3
– Sell
-8,596
Closed -$3.34M – 145
2025
Q2
$3.34M Sell
8,596
-938
-10% -$377K 0.37% 69
2025
Q1
$4.15M Hold
9,534
– – 0.45% 58
2024
Q4
$3.52M Sell
9,534
-1,239
-12% -$518K 0.36% 70
2024
Q3
$5.39M Hold
10,773
– – 0.58% 44
2024
Q2
$5.84M Buy
+10,773
New +$5.69M 0.56% 41

Other funds holding ELV

BDF Gestion's ELV Position: Q3 2026 in Review

BDF Gestion reduced its Elevance Health (ELV) stake by 11% in Q3 2026, selling an estimated $188K and leaving 3,710 shares worth $1.44M. The position accounts for 0.2% of the portfolio, ranked #119.

BDF Gestion first reported a position in ELV in Q2 2024 and has held it in 8 quarters since. The position peaked at $5.84M in Q2 2024. 236 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • BDF Gestion held 3,710 shares of Elevance Health worth $1.44M as of Q3 2026.
  • BDF Gestion sold 471 Elevance Health shares in Q3 2026, an estimated $188K.
  • Elevance Health made up 0.2% of BDF Gestion's portfolio in Q3 2026, its #119 holding.
  • BDF Gestion first reported a position in Elevance Health in Q2 2024 and has held it in 8 quarters since.
  • BDF Gestion's Elevance Health position peaked at $5.84M in Q2 2024.
  • 236 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on BDF Gestion's 13F filing for Q3 2026, filed 19 Oct 2026.